Home / Products / Impurities / Apremilast
Apremilast was approved by the US Food and Drug Administration (FDA) in 2014. Apremilast is used in treatment for psoriatic arthritis. Apremilast is also used to treat skin conditions. Apremilast is a small-molecule inhibitor of PDE4. Apremilast Degradation Impurities, Apremilast Process Impurities, Apremilast Potential Impurities, Apremilast USP Related Compound, Apremilast N-Nitroso impurities, Apremilast nitrosamine impurities etc. are listed below
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here